Detalles de la búsqueda
1.
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nat Immunol
; 22(1): 74-85, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32999467
2.
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.
Nature
; 601(7894): 617-622, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34814158
3.
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Am J Respir Crit Care Med
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626354
4.
Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer.
Br J Cancer
; 120(1): 97-108, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30377343
5.
Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine.
Int J Mol Sci
; 20(8)2019 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31018546
6.
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma.
Cancer Immunol Immunother
; 67(2): 237-246, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29058035
7.
Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.
BMC Cancer
; 18(1): 1071, 2018 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30400840
8.
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
Br J Haematol
; 179(4): 586-597, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961309
9.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
Breast Cancer Res Treat
; 161(1): 63-72, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27798749
10.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Lancet Oncol
; 17(12): 1697-1708, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27776843
11.
A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
Cancer
; 122(9): 1425-33, 2016 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26949913
12.
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
Proc Natl Acad Sci U S A
; 110(44): 17945-50, 2013 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24127572
13.
SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.
BMC Cancer
; 15: 300, 2015 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25928859
14.
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.
Proc Natl Acad Sci U S A
; 109(15): 5797-802, 2012 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22454499
15.
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.
Int J Cancer
; 134(10): 2314-21, 2014 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24174373
16.
A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens.
Cancer Immunol Immunother
; 63(12): 1251-9, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25143232
17.
NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.
Cancer Immun
; 13: 12, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23882157
18.
Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study.
BMC Cancer
; 13: 272, 2013 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23731674
19.
A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel.
J Cardiovasc Pharmacol
; 61(6): 495-504, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23429593
20.
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer.
J Immunother Cancer
; 11(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627144